Second, the humanized L3D10 clones HL12 and HL32, which have lost the ability to block the B7-CTLA-4 interaction regardless of whether CD80 is immobilized or in soluble form, are potent inducers of tumor rejection. The gene discussed is CD80; the disease is neoplasm.